Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation

被引:9
|
作者
Sclair, Seth N. [1 ,2 ]
Fiel, Maria Isabel [3 ]
Wu, Hai-Shan [3 ]
Doucette, John [4 ]
Aloman, Costica [5 ,6 ]
Schiano, Thomas D. [2 ,7 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Med, Div Hepatol, Miami, FL 33136 USA
[2] Icahn Sch Med Mt Sinai, Div Liver Dis, Dept Med, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Dept Publ Hlth, New York, NY 10029 USA
[5] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA
[6] Univ Illinois, Dept Surg, Div Transplant Surg, Chicago, IL 60680 USA
[7] Icahn Sch Med Mt Sinai, Recanati Miller Transplant Inst, New York, NY 10029 USA
关键词
cirrhosis; fibrosing cholestatic hepatitis; hepatitis C virus; liver transplantation; DONOR AGE; FIBROSIS PROGRESSION; C VIRUS; NATURAL-HISTORY; SURVIVAL; GRAFT; REGENERATION; RETRANSPLANTATION; CLASSIFICATION; EXPRESSION;
D O I
10.1111/ctr.12740
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: Post-liver transplant (LT) hepatitis C virus (HCV) patients may develop allograft cirrhosis and rarely fibrosing cholestatic hepatitis (FCH), while others have a stable course. Hepatic progenitor cells (HPC) may be implicated in liver injury and fibrogenesis through ductular reaction (DR). We studied HPC response and DR in three distinct post-LT patterns of HCV: stable recurrence, allograft cirrhosis, and FCH. Methods: We identified 52 patients with untreated recurrent HCV and longitudinal liver biopsies (20 stable/23 cirrhosis/9 FCH) and eight healthy controls. Archived liver biopsy specimens for three time points (LT; initial recurrence; and clinical outcome) were stained for cytokeratin-7. Manual HPC counts and DR quantification using image analysis were performed. Results: HCV counts and DR at LT did not differ across groups. At initial recurrence, HPC expansion occurred only in patients who developed cirrhosis, while prominent DR was present in those who developed FCH vs. stable and controls (p < 0.05). At outcome biopsies, HPC response and DR were increased in cirrhosis and FCH vs. stable and controls (p < 0.05). HPC response and DR did not differ in stable vs. controls. Conclusions: These findings suggest that an altered HPC response assessed by cytokeratin-7 stain after LT may predict severity of HCV recurrence.
引用
收藏
页码:722 / 730
页数:9
相关论文
共 50 条
  • [21] Severity and response to therapy of recurrent HCV post living donor liver transplantation.
    Kontorinis, N
    Elhajj, N
    Agarwal, K
    Eggleton, E
    Barton, C
    Roayaie, S
    Schwartz, M
    Schiano, T
    [J]. HEPATOLOGY, 2004, 40 (04) : 564A - 564A
  • [22] Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
    Patel, Neal
    Bichoupan, Kian
    Ku, Lawrence
    Yalamanchili, Rachana
    Harty, Alyson
    Gardenier, Donald
    Ng, Michel
    Motamed, David
    Khaitova, Viktoriya
    Bach, Nancy
    Chang, Charissa
    Grewal, Priya
    Bansal, Meena
    Agarwal, Ritu
    Liu, Lawrence
    Im, Gene
    Leong, Jennifer
    Kim-Schluger, Leona
    Odin, Joseph
    Ahmad, Jawad
    Friedman, Scott
    Dieterich, Douglas
    Schiano, Thomas
    Perumalswami, Ponni
    Branch, Andrea
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (09) : 2844 - 2854
  • [23] The effects of SVR and early HCV treatment on metabolic risk factors in patients post-liver transplantation.
    Sharma, Rajani
    Laurito, Marcela
    Brown, Robert S.
    Verna, Elizabeth C.
    [J]. HEPATOLOGY, 2017, 66 : 879A - 879A
  • [24] Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
    Neal Patel
    Kian Bichoupan
    Lawrence Ku
    Rachana Yalamanchili
    Alyson Harty
    Donald Gardenier
    Michel Ng
    David Motamed
    Viktoriya Khaitova
    Nancy Bach
    Charissa Chang
    Priya Grewal
    Meena Bansal
    Ritu Agarwal
    Lawrence Liu
    Gene Im
    Jennifer Leong
    Leona Kim-Schluger
    Joseph Odin
    Jawad Ahmad
    Scott Friedman
    Douglas Dieterich
    Thomas Schiano
    Ponni Perumalswami
    Andrea Branch
    [J]. World Journal of Gastroenterology, 2016, 22 (09) : 2844 - 2854
  • [25] SIGNIFICANTLY INCREASED POST-LIVER TRANSPLANTATION MORTALITY AMONG PATIENTS AGE 70 YEARS AND OLDER
    Wong, R. J.
    Ahmed, A.
    Esquivel, C.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S363 - S364
  • [26] Distinct differences in global immune cell function profiles between HCV(+) and HCV(-) post-liver transplant patients.
    Kwok, Hansen
    Chang, Nancy
    Weissman, Jill
    Franco, Edson S.
    Kayali, Zeid
    Baron, Pedro W.
    Ojogho, Okechukwu
    Mendler, Michel H.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A756 - A756
  • [27] Post-Liver Transplantation (LT) Outcome in HIV/HCV Co-Infected Patients. Comparison with Monoinfected Patients with HCV-Cirrhosis
    Aguilera, Victoria
    Vinaixa, Carmen
    Blanes, Marino
    Rubin, Angel
    Garcia, Maria
    Ortiz, Cecilia
    Montalva, Eva
    Lopez-Andujar, Rafael
    Berenguer, Marina
    Prieto, Martin
    Mir, Jose
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S97 - S98
  • [28] POST-LIVER TRANSPLANTATION (LT) OUTCOME IN HIV/HCV CO-INFECTED PATIENTS. COMPARISON WITH MONOINFECTED PATIENTS WITH HCV-CIRRHOSIS
    Aguilera, V.
    Vinaixa, C.
    Rubin, A.
    Castello, B.
    Blanes, M.
    San Juan, F.
    Lopez-Andujar, R.
    Berenguer, M.
    Prieto, M.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S212 - S212
  • [29] HCV treatment with DAA in patients listed for liver transplant does not result in an increased risk of HCC recurrence post-liver transplant
    Mazzarelli, C.
    Invernizzi, F.
    Suddle, A.
    Donato, M. F.
    Belli, L. S.
    Cannon, M. D.
    Marenco, S.
    Angrisani, D.
    Iavarone, M.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S117 - S118
  • [30] Histological criteria for the distinction of hepatitis C recurrence post-liver transplantation in patients with other hepatic complications
    Bessissow, T
    Marcus, V
    Deschenes, M
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A732 - A732